ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000230806.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.04916013	Resistant
ENSG00000230806.1	ABT-263 (navitoclax)	Liver hepatocellular carcinoma	0.019502549	Sensitive